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ABSTRACT 
This study developed a method for furosemide quantification through high performance 
liquid chromatographic technique. Special attention was given to solute loss and storage 
stability due to furosemide’s low solubility and photosensitivity, respectively. The performance 
of Nylon and PVDF filters was tested in a 2 mg.L-1 furosemide solution. PVDF filters showed 
better recovery capacity and therefore are more suitable for furosemide filtration.  Over eight 
days, three different storage conditions were studied to access furosemide degradation 
susceptibility: (i) exposure to light at room temperature, (ii) storage at room temperature 
without exposure to light, and (iii) storage at 4ºC without exposure to light. The study 
demonstrated that after 48 h under natural light exposure furosemide was completely degraded. 
Furosemide solution stored in the dark was stable. Storage temperature did not seem to affect 
furosemide concentration. The study shows that the selection of more suitable filter and storage 
conditions for furosemide determination is crucial to avoid underestimation errors. 
Keywords: filter retention, pharmaceutical, photodegradation. 
Furosemida em matriz de água: desenvolvimento de um método 
HPLC-UV e estudos de degradação 
RESUMO 
O presente estudo desenvolve um método para a quantificação de furosemida através de 
cromatografia de alta resolução. Devido à baixa solubilidade do composto e à sua 
fotossensibilidade, neste estudo avaliou-se as possíveis perdas do composto ao longo do método 
de quantificação e a sua estabilidade durante o armazenamento ao longo de oito dias.  Para tal, 
foram testados dois filtros (Nylon e PVDF) com o mesmo diâmetro e tamanho de poro para 
uma concentração de furosemida de 2 mg.L-1. A degradação da furosemida foi estudada para 
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três condições diferentes de armazenamento: com exposição solar à temperatura ambiente, sem 
exposição solar à temperatura ambiente e sem exposição solar a 4°C. O estudo demonstrou que 
o composto furosemida atinge a degradação completa com exposição solar após 48h. A solução 
de furosemida permaneceu estável ao longo da experiência quando protegida da luz. A 
temperatura de armazenamento não parece afetar a concentração da solução de furosemida. O 
presente estudo mostrou que para análises da furosemida, a escolha do filtro adequado e as 
condições de armazenamento devem ser consideradas para evitar erros de subestimação. 
Palavras-chave: fármaco, foto degradação, retenção do filtro. 
1. INTRODUCTION 
The presence of pharmaceutical active compounds (PhACs) in different water bodies is 
well documented in several studies (Böger et al., 2018; Kuster et al., 2008; Paíga and Delerue-
Matos, 2016; Pereira et al., 2017). After ingestion, pharmaceuticals are only partially absorbed 
and the remainder is excreted as the parent compound or their metabolites via urine or feces. 
Conventional wastewater treatment processes are not completely efficient in removing PhACs 
(Ternes, 1998; Martín et al., 2012). Therefore, the development of methods to correctly quantify 
these compounds in specific matrices are required, and several options already exist. 
Environmental studies commonly determine the presence of PhACs in samples using methods 
for the determination of a broad variety of compounds (Cruz-Morató et al., 2014). Although 
this approach brings benefits such as reductions in time and cost, some inherent restrictions to 
the accuracy of the determination of each compound is associated, such as analyte loss due to 
membrane filter adsorption. HPLC-UV analyses requires samples to be filtered to avoid 
clogging the equipment and capillaries and to extend the column’s lifespan (Carlson and 
Thompson, 2000). Moreover, compound stability studies are also necessary to prevent 
associated quantification errors, particularly along analyses procedures. For some pollutants, 
the knowledge of all interferences in the quantification process are still not fully known and 
require further investigation.  
In Europe, anti-hypertensive substances, recently included in the cardiovascular system 
pharmacotherapeutic group, have the highest consumption rates (OECD, 2016). Included in this 
group, furosemide (FUR) is a loop diuretic pharmaceutical prescribed to treat cases of 
hypertension and edema (Bosch et al., 2008). In Portugal in 2014, FUR occupied the 15th place 
in the top 100 active substances ranking with the highest number of packages sold in the 
National Health System (INFARMED, 2014). According to Prandota and Witkowska (1976), 
after human consumption up to 70% of furosemide is absorbed. However, 90% of the non-
absorbed drug is excreted as the parent compound (Zuccato et al., 2005). Therefore, in countries 
such as Portugal, FUR is expected to be found in wastewater treatment plants (WWTPs) (Santos 
et al., 2013). According to the literature, the presence of FUR in WWTP influents and effluents 
can widely fluctuate from mg.L-1 to ng.L-1 (Jelic et al., 2011; Salgado et al., 2010; Santos et al., 
2013), while in surface water bodies it usually occurs in low concentrations of µg.L-1 to ng.L-1 
(Silva et al., 2011; Valcárcel, 2011; Matamoros et al., 2012).  
Although several studies show the presence of FUR in different environmental samples, 
its concentration varies widely, inducing uncertainty in the PhAC relevance in terms of 
environment contamination and particularly in the accurate efficiency assessment of the 
WWTPs on removing this contaminant. Therefore, developing a quantification method for FUR 
that accounts for the different interferences that can exist along the analyses is vital. Moreover, 
the use of simple matrices such as ultrapure water for preliminary tests can provide more clear 
results, especially for compounds such as FUR that are hydrophobic and have low solubilities 
(Table 1), and thus are more prone to be lost during simple sample preparation procedures, such 
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as filtration. Saturation of the filter adsorption sites generally can minimize these losses (Pillai 
et al., 2016). However, sometimes the sample volume is not enough for pre-wetting the filters, 
and thus the selection of the most suitable type of filter can be a key aspect. 
Table 1. Structure, physical and chemical properties of furosemide. 




Molecular formula C12H11ClN2O5S 
Molecular weight (g.mol-1) 330.75a 
Melting Point (˚C) 206a 
Ionisation constant, pKa pKa= 3.8b 
Octanol/Water Partition Coefficient, log Kow 2.03c 
Water solubility, at 30˚C (mg.L-1) 73.1d 
Source: aO’Neil (2001). bBerthod et al. (1999). cSangster (2001). dYalkowsky 
and Dannenfelser (1992). 
Another relevant factor is that the literature on methodologies for FUR quantification as a 
single target is only common in the scope of human or animal health, or for pharmaceutical 
dosage control (Bosch et al., 2008). Hence, most of the studies on FUR determination were 
performed in matrices of human and animal urine or plasma. The complexity of such matrices 
can mask other interferences along the analytical procedure. 
This study sought to contribute to the definition of an appropriate methodology for FUR 
determination in a water matrix by HPLC-UV and to better understand the stability of the 
compound along the analysis-preparation procedure. 
2. MATERIALS AND METHODS 
2.1. Chemicals and materials 
Analytical grade furosemide (99.8% purity) was purchased from Sigma-Aldrich (Lisbon, 
Portugal); see Table 1 for its main characteristics. Phosphoric acid (>85% purity), HPLC-grade 
solvents acetonitrile and methanol were obtained from Enzymatic, S.A. (Loures, Portugal). 
Ultra-pure water was prepared from a Millipore Milli Q system. Both Whatman 13 Puradisc 
syringe filters (nylon and PVDF - Polyvinylidene fluoride) were supplied by Enzymatic, S.A. 
(Loures, Portugal). 
2.2. Standards solutions 
Furosemide stock standard solution containing 10 mg.L-1 was prepared. Furosemide was 
dissolved in 1 ml of methanol and filled to the 1 L mark with ultra-pure water. An ultrasonic 
bath was used to help the dissolution of furosemide. For furosemide quantification, standard 
solutions were prepared within the range of 0.1-4 mg.L-1. All solutions were stored in the dark 
and covered with aluminium foil to avoid photodegradation. The 10 mg.L-1 FUR solution was 
scanned between the 190 and 350 nm UV region. The wavelength of 233 nm corresponding to 
the maximum absorption peak has been therefore selected to carry on the experiment.  Electric 
conductivity and pH were also assessed. 
2.3. Quantification and analytical method validation 
Furosemide quantification was carried out in a HPLC - Beckman Coulter System Gold, 
with a Solvent Module 126 and a Diode Array Detector 168, using 32 Karat Software, version 
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8.0, with a variable wavelength detector (190-800 nm) at 233 nm and with a 20 µL volume 
injector loop. Samples were determined with a flow rate of 1 mL.min-1. A reversed-phase 
analytical column Zorbax Eclipse XDB-C8 (4.6x150 mm; 5 µm) was used. The composition of 
the mobile phase used in furosemide analyses was previously selected for an isocratic elution 
mode using trial mixtures of acetonitrile and ultra-pure water acidified with phosphoric acid 
(0.1% v/v) in different proportions (50:50, 55:45, 60:40, 65:35 and 70:30). The mixture 
composed of 60% acetonitrile and 40% ultra-pure water (acidified with phosphoric acid) was 
selected, as the corresponding retention time for furosemide was below 4 min., thereby allowing 
the quantification of the pharmaceutical in a reasonably short time. Samples were injected (three 
replicates) with an automatic injector manufactured by Spark Holland BV – MIDAS, at room 
temperature (16-20˚C). 
This analytical method was validated according to the International Conference on 
Harmonization (ICH) guidelines for validation of analytical procedures (United States, 1996), 
based on the following parameters: linearity, sensitivity, precision (intra-day) and accuracy. 
A calibration curve was constructed using a set of furosemide standard solutions with 
concentrations of 0.1-4 mg.L-1. Three replicate injections were made for each standard solution. 
The regression equation and the value of the correlation coefficient were calculated using linear 
regression analysis. The sensitivity of the analytical method was estimated in terms of the limits 
of detection (LOD) and of quantification (LOQ). LOD and LOQ were defined based on signal-
to-noise ratios of 3:1 and 10:1, respectively. Moreover, for the assessment of the analytical 
method’s accuracy and precision (intra-day), standard solutions at seven different 
concentrations (from 0.25 mg.L-1 to 4 mg.L-1) were injected at three different times in the same 
day. The precision of the proposed method was obtained by calculating the relative standard 
deviation (RSD) values of the peak areas for the three different injections with acceptance 
criteria of not more than 2% (United States, 1996). The accuracy of the quantification method 
was assessed through the percentage ratio between the measured concentrations of the 
furosemide standards and their nominal concentrations. 
2.4. Procedure 
Different syringe filters were tested to study the FUR recovery percentage throughout the 
process. Nylon and PVDF (Polyvinylidene fluoride), both with 0.45 µm pore size as 
recommended for HPLC analysis, were selected. The filter size (13 mm) was chosen in 
accordance with the low sample volume required for further analysis. Through HPLC analysis, 
filter recovery capacity was tested for 2 mg.L-1 of FUR solution, filtering a volume of 2 mL. 
Additionally, the recovery capacity was further validated comparing a standard curve, between 
0.25 and 2 mg.L-1 of FUR, with and without filtration. 
For FUR degradation studies, an experiment over 8 days was performed under three 
different storage conditions. At room temperature (12-18˚C), three replicates of a FUR solution 
with approximately 2 mg.L-1 were exposed to daylight (L), and the other three were kept in the 
dark (D) to test photodegradation sensitivity. The effect of storage temperature was tested with 
another three replicates that were kept at 4˚C. Samples were taken from all the standard 
solutions after 0, 24, 48, 72 and 192 hours of exposure and analysed through HPLC. 
3. RESULTS AND DISCUSSION 
3.1. Furosemide quantification 
3.1.1. Furosemide recovery  
Figure 1 compares the extent of FUR retention by two different filters, Nylon and PVDF, 
for the same solution. Nylon filters presented 75% more FUR adsorption than PVDF filters. 
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Hence, the PVDF filter seems more efficient for FUR solution filtration. Several factors can 
affect adsorption onto membranes, from characteristics of the compounds to the properties of 
the filters. Both filters have hydrophilic membranes, the same pore size (0.45µm) and the same 
effective filter area (1.3 cm2). Nylon filters, compared with PVDF, bind proteins and are more 
suitable for filtering samples with a high pH. In turn, PVDF filters are highly inert and have 
low protein binding (GE Healthcare, 2018). Since the standard samples have a pH of 5.5±0.17, 
both filters were appropriate. Hence, the results can be an outcome of the inert feature of the 
PVDF filters. To further validate the PVDF filters’ suitability, a comparison of a standard curve 
with and without filtration was performed (see Figure 2). No significant losses were observed. 
Therefore, the PVDF filter was considered appropriate to carry on experiments with FUR. 
 
Figure 1. FUR retention (2 mg.L-1) in Nylon and PVDF filters. 
 
Figure 2. Standard curve of FUR for samples without filtration 
and filtered through PVDF filters. 
3.1.2. Method validation 
An optimal peak shape and retention time of FUR was obtained for the selected 
chromatographic conditions (Figure 3). The method employed also showed a linear pattern for 
the tested concentration range (0.1-4.0 mg.L-1) with a correlation r2=0.9999 (Figure 4).  Limit 
of quantification (LOQ) was 0.144 mg.L-1 and limit of detection (LOD) was 0.048 mg.L-1 
(Equations 1 and 2, respectively). The accuracy of the method was estimated to be within 93.7-
101.8%, whereas in regard to the intra-day precision, RSD of measurements were below 2%. 
Therefore, the method can be considered to provide a good sensitivity, precision and accuracy. 
𝐿𝑂𝑄 =  
10 x σ
𝑠𝑙𝑜𝑝𝑒 𝑜𝑓 𝑐𝑎𝑙𝑖𝑏𝑟𝑎𝑡𝑖𝑜𝑛 𝑐𝑢𝑟𝑣𝑒
                 (1) 
𝐿𝑂𝐷 =  
3.3 x σ
𝑠𝑙𝑜𝑝𝑒 𝑜𝑓 𝑐𝑎𝑙𝑖𝑏𝑟𝑎𝑡𝑖𝑜𝑛 𝑐𝑢𝑟𝑣𝑒
              (2) 
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Figure 3. Chromatogram of FUR in ultrapure water matrix. 
 
Figure 4. Linearity of FUR in an ultrapure water matrix. 
3.2. Degradation studies 
Figure 5 shows FUR stability over 8 days under different storage conditions. The FUR 
solutions kept from light exposure maintained their concentration throughout the experiment. 
Storage temperature does not seem to affect FUR concentration. Moreover, since FUR 
quantification is performed at room temperature, FUR-solution storage should benefit if similar 
temperatures are maintained to avoid potential precipitation. Figure 5 shows that during the first 
24h of exposure there is a slight increase in concentration in 4D solutions.  The minor increase 
is due to the initial lower values of one of the replicates. Poor initial solubility of the replicate 
could explain the lower value at 0 hours of exposure, compared to the 24-hour sample.   
 
Figure 5. FUR conservation over 8 days for three 
different conditions: L – Light exposure at room 
temperature; D – Kept in the dark at room 
temperature; and, 4D – Kept in the dark at 4˚C. 
FUR's sensitivity to light is well-documented, and the appearance of photodegradation 
products as a result of the exposure to light is to be expected (Greca et al., 2004). In fact, Figure 
6a shows the presence of two new peaks (2 and 3) along with the peak of FUR (1).  Substance 
(3) appears in all samples after 24h and disappears before 48h of exposure; therefore, light 
exposure and temperature are not the key factors to explain this phenomenon. Moreover, 
substance (3) seems to suffer further degradation since it disappears after 48h.  
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In the first 72h of exposure, the decrease of FUR is followed by an increase of the 
concentration of substance (2). Afterwards, substance (2) decreases to concentrations below 
detection levels. Greca et al., (2004) tested the photodegradation of furosemide in different 
water matrices through a 150-W solar simulator over 36h. In all water matrices, including a 
simple distilled water medium, only one new photoproduct was found.  The same result 
occurred when the distilled water solution was exposed to natural solar radiation. Therefore, 
the main photoproduct mentioned above, substance (2), which is visible in the solution exposed 
to light, can be the same as the one found in the previously referred to work. FUR, in aqueous 
solutions exposed to UV light, hydrolyses into 2-amino-4-chloro-5 sulfamoylanthranilic acid 
(CSA) and furfuryl alcohol that will be further degraded into levulinic acid (Ruiz‐Angel et al., 
2006). Therefore, substance (2) could be the FUR photoproduct CSA, but further liquid 
chromatography mass spectrometry analysis should be undertaken for substance identification 
(Figure 7). 
 
Figure 6. Chromatogram of furosemide in ultrapure 
water under: a) light exposure/room temperature; b) 
darkness/room temperature; c) darkness/4˚C. Continue. 
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Figure 6. Continue. 
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Figure 7. a) Furosemide photodegradation over eight days; b) First-order kinetic of 
furosemide photodegradation. 
4. CONCLUSIONS 
The developed method allows fast and accurate determination of FUR in water solution by 
HPLC-UV. In the 0.1-4 mg.L-1 concentration range, the quantification of FUR follows a linear 
regression. Due to its low solubility and sorption susceptibility, FUR standard solutions should 
be filtered through PVDF filters or others with a similar inert feature. Stability studies validated 
the well-known photo sensitivity characteristic of FUR. Total photodegradation of a FUR 
solution was achieved after 48h of exposure to natural light. Therefore, it is recommended that 
FUR standards solutions should be stored in the dark at room temperature to guarantee 
concentration conservation. The study emphasizes that when targeting FUR in low volume 
environmental samples, special attention should be given to the chosen filter, as well as to 
storage conditions to avoid underestimation errors. 
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